Howard I. Scher

Also affiliated with Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Papers

Driven by 42 papers — median percentile 0. Top paper: “Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis”.

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Nature(2005)10.1038/nature03918

N/A

17.4DataRank · unranked

1982 citations

Lloyd C. Trotman, David Shaffer, Hui-Kuan Lin, Zohar A. Dotan, Masaru Niki +7 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.986DataRank · unranked

717 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1090

N/A

0.589DataRank · unranked

10 citations

Karim Fizazi, Fred Saad, Kim N. Chi, Mary-Ellen Taplin, Cora N. Sternberg +5 more

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting

The Prostate(2020)10.1002/pros.24056

N/A

0DataRank · unranked

28 citations

Kenneth J. Pienta, John W. Babich, Neil H. Bander, Jérémie Calais, Peter L. Choyke +11 more

PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.11.294264

N/A

0DataRank · unranked

3 citations

Claire M. Storey, Katharina Lückerath, Katharina Braun, Christian von Bodman, Urpo Lamminmäki +16 more

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.183

N/A

0DataRank · unranked

2 citations

Susan Halabi, Joseph D. Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou +13 more

AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.184

N/A

0DataRank · unranked

1 citations

Jun Luo, Monika Anand, Emmanuel S. Antonarakis, David M. Nanus, Paraskevi Giannakakou +10 more

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer

UNC Libraries(2020)10.17615/41rk-2070

N/A

0DataRank · unranked

0 citations

Matthew D. Galsky, Iain J. Webb, Jesika Petruck, Michael J. Morris, Robert Dreicer +7 more

Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study

UNC Libraries(2020)10.17615/yxdm-6w50

N/A

0DataRank · unranked

0 citations

Christopher J. Sweeney, Frauke Schimmöller, Dana E. Rathkopf, Naomi B. Haas, Celestia S. Higano +16 more

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Genome Medicine(2021)10.1186/s13073-021-00898-8

N/A

0DataRank · unranked

58 citations

Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won +32 more

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3471

N/A

0DataRank · unranked

37 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3614

N/A

0DataRank · unranked

23 citations

Claire M. Storey, Katharina Lückerath, Katharina Braun, Christian von Bodman, Urpo Lamminmäki +16 more

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

European Urology Open Science(2021)10.1016/j.euros.2021.09.015

N/A

0DataRank · unranked

19 citations

Emmanuel S. Antonarakis, Tina Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan +22 more

Correlation Between Imaging-Based Intermediate Endpoints and Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: Analysis of 28 Randomized Trials Using the Prostate Cancer Clinical Trials Working Group (PCWG2) Criteria in 16,511 Patients

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.11.007

N/A

0DataRank · unranked

9 citations

Chong Hyun Suh, Andreas G. Wibmer, Anton S. Becker, Min Yuen Teo, Mithat Gönen +5 more

Multilineage plasticity in prostate cancer through expansion of stem–like luminal epithelial cells with elevated inflammatory signaling

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.01.466599

N/A

0DataRank · unranked

7 citations

Jimmy L. Zhao, Joseph M. Chan, Martine P. Roudier, Kristine M. Wadosky, Anuradha Gopalan +25 more

Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17039

N/A

0DataRank · unranked

4 citations

Luisa Fernandez, Kate Cunningham, Natalie Elphick, Ethan Barnett, Jerry S. H. Lee +11 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Optimizing the future: how mathematical models inform treatment schedules for cancer

Trends in cancer(2022)10.1016/j.trecan.2022.02.005

N/A

0DataRank · unranked

49 citations

Ethan Barnett, Howard I. Scher, João B. Xavier, Deepti Mathur

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

Journal of Clinical Investigation(2022)10.1172/jci161858

N/A

0DataRank · unranked

33 citations

Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh +34 more

Spine Pain and Metastatic Prostate Cancer: Defining the Contribution of Nonmalignant Etiologies

JCO Oncology Practice(2022)10.1200/op.21.00816

N/A

0DataRank · unranked

11 citations

Erica Simone Dayan, Niamh M. Keegan, Abigail Bacharach, Sungmin Woo, Theresa A. Gillis +2 more

Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.02.002

N/A

0DataRank · unranked

7 citations

Glenn Heller, Joseph Fox, Daniel C. Danila, Anders Bjartell, Lars Edenbrandt +4 more

Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0574

N/A

0DataRank · unranked

4 citations

Bradford P. Taylor, Walid K. Chatila, Howard I. Scher, Nikolaus Schultz, Pedram Razavi +2 more

Evaluation of an Integrated Spectroscopy and Classification Platform for Point-of-Care Core Needle Biopsy Assessment: Performance Characteristics from Ex Vivo Renal Mass Biopsies

Journal of Vascular and Interventional Radiology(2022)10.1016/j.jvir.2022.07.027

N/A

0DataRank · unranked

1 citations

Dmitry V. Dylov, Siavash Yazdanfar, Dharam Patel, Tarik Silk, Mikhail Silk +9 more

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5026

N/A

0DataRank · unranked

0 citations

Andrea Arfè, Ethan Barnett, Erica Simone Dayan, Jimmy L. Zhao, Emily Carbone +5 more

Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer

Journal of Immunotherapy and Precision Oncology(2023)10.36401/jipo-23-9

N/A

0DataRank · unranked

5 citations

Justine Anderson, Daniel C. Danila, Michael J. Morris, Susan F. Slovin, Wassim Abida +5 more

Data from Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine–Rich Tetratricopeptide Repeat Containing Protein α

(2023)10.1158/0008-5472.c.6496634

N/A

0DataRank · unranked

0 citations

Carmela Ricciardelli, Jonathan M. Harris, Jennifer Prescott, Zoe Chiao-Li Yu, Li Jia +7 more

Data from Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

(2023)10.1158/1078-0432.c.6530474.v1

N/A

0DataRank · unranked

0 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

Data from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates

(2023)10.1158/1078-0432.c.6530559.v1

N/A

0DataRank · unranked

0 citations

Claire M. Storey, Katharina Lückerath, Katharina Braun, Christian von Bodman, Urpo Lamminmäki +16 more

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0DataRank · unranked

54 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

Two decades of advances in clinical oncology — lessons learned and future directions

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00945-4

N/A

0DataRank · unranked

23 citations

Christopher M. Booth, Éduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry +14 more

Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer

European Journal of Cancer(2024)10.1016/j.ejca.2024.114257

N/A

0DataRank · unranked

5 citations

Tatiana Erazo, Justin Jee, Andrea Arfè, Avantika Gupta, Luke Pike +28 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.264

N/A

0DataRank · unranked

0 citations

Jessica Flynn, Binsheng Zhao, Aseem Anand, Karl Sjöstrand, Steven M. Larson +7 more

Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancer

medRxiv(2025)10.1101/2025.07.01.25330467

N/A

0DataRank · unranked

0 citations

Alexander Martinez‐Fundichely, Sandra Cohen, Metin Balaban, Chen Khuan Wong, Weiling Li +26 more

Anti-tumour effects of perioperative ketamine in lung cancer: a non-randomised, exploratory biomarker study

British Journal of Anaesthesia(2025)10.1016/j.bja.2025.08.004

N/A

0DataRank · unranked

0 citations

Anya Shah, Jeremy Mason, Joseph R. Scarpa, David Amar, Dawn P. Desiderio +15 more

Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.07.007

N/A

0DataRank · unranked

5 citations

Hebert Alberto Vargas, Daniel J. Holzwanger, Heiko Schöder, Emily Waters, Elena N. Petre +13 more

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa095

N/A

0DataRank · unranked

65 citations

Dana L. Casey, Yue Christine Lu, Margaret Hannum, Zhigang Zhang, Xinmao Song +26 more

Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-1216

N/A

0DataRank · unranked

42 citations

Jimmy L. Zhao, Adam Jendrisak, Emily Carbone, Ethan Barnett, Melanie Hullings +11 more

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.10.013

N/A

0DataRank · unranked

33 citations

Jay Chudow, Mia DeNunzio, Susan F. Slovin, Daniel C. Danila, Michael J. Morris +3 more

Howard I. Scher

Indexed papers

Top data-sharing exemplar

Papers